Loading…
Indo Borax & Chemicals (INDOBORAX)₹375.70−3.80%Commodity Chemicals
In the Jun 2026 quarter (consolidated), Indo Borax & Chemicals reported sales of ₹69.93 Cr, up 29.6% from Jun 2025, and net profit of ₹15.94 Cr, up 59.9% year on year. For the year to Mar 2026, sales were ₹215 Cr and net profit ₹49.86 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46.97 | 43.99 | 45.01 | 49.95 | 37.99 | 37.99 | 49.95 | 53.97 | 58.01 | 40.97 | 62.97 | 69.93 |
| Expenses | 36.92 | 34.89 | 33.94 | 32.92 | 28.94 | 26.94 | 39.91 | 40.87 | 46.87 | 31.94 | 49.88 | 50.83 |
| Operating Profit | 10.03 | 9.02 | 12.03 | 16.03 | 9.02 | 10.03 | 10.02 | 12.04 | 10.03 | 9.03 | 13.04 | 20.05 |
| OPM % | 22.0% | 21.1% | 25.1% | 33.0% | 24.0% | 27.0% | 20.0% | 23.1% | 18.0% | 21.0% | 20.1% | 28.1% |
| Other Income | 2.99 | 2.99 | 2.99 | 2.99 | 3.99 | 3.99 | 3.99 | 2.99 | 12.98 | 3.99 | 4.99 | 2.99 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 |
| Profit before tax | 12.02 | 11.02 | 14.04 | 19.05 | 13.03 | 14.04 | 13.04 | 14.04 | 23.06 | 12.03 | 17.05 | 22.05 |
| Tax % | 27.0% | 27.0% | 20.0% | 27.0% | 29.0% | 34.0% | 20.0% | 29.0% | 28.0% | 24.0% | 17.0% | 26.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.01 | 0.00 | 1.01 | 0.00 |
| Net Profit | 8.97 | 7.97 | 10.97 | 13.96 | 8.97 | 8.97 | 9.97 | 9.97 | 15.94 | 8.97 | 14.96 | 15.94 |
| EPS (Rs) | 2.77 | 2.57 | 3.57 | 4.38 | 2.87 | 2.84 | 3.18 | 3.19 | 5.08 | 2.90 | 4.52 | 5.07 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 69.97 | 66.95 | 101 | 128 | 115 | 144 | 176 | 225 | 191 | 175 | 215 | 232 |
| Expenses | 56.87 | 55.83 | 82.73 | 108 | 96.81 | 99.68 | 128 | 163 | 149 | 129 | 171 | 180 |
| Operating Profit | 12.04 | 10.03 | 18.06 | 20.05 | 19.05 | 44.14 | 48.14 | 62.12 | 43.10 | 46.11 | 44.13 | 52.15 |
| OPM % | 18.1% | 15.1% | 17.1% | 16.0% | 16.1% | 31.1% | 27.1% | 28.0% | 22.1% | 26.0% | 21.1% | 22.5% |
| Other Income | 2.99 | 2.99 | 3.99 | 5.99 | 4.99 | 3.99 | 2.99 | 8.98 | 11.98 | 15.97 | 24.96 | 24.95 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 | 2.99 | 2.99 | 2.97 |
| Profit before tax | 14.04 | 12.02 | 20.06 | 24.05 | 22.07 | 47.14 | 50.13 | 69.21 | 52.16 | 59.17 | 67.21 | 74.19 |
| Tax % | 32.0% | 31.0% | 34.0% | 28.0% | 24.0% | 26.0% | 27.0% | 26.0% | 25.0% | 28.0% | 24.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 2.01 | 1.01 | 2.01 | 14.02 | 8.02 |
| Net Profit | 8.98 | 7.98 | 12.96 | 17.95 | 16.96 | 33.90 | 35.90 | 50.84 | 38.89 | 42.87 | 49.86 | 55.81 |
| EPS (Rs) | 2.89 | 2.48 | 4.18 | 5.47 | 5.29 | 10.68 | 11.34 | 15.82 | 12.16 | 13.24 | 15.66 | 17.57 |
| Dividend payout % | 5.0% | 6.1% | 4.0% | 3.0% | 4.0% | 9.1% | 1.0% | 6.0% | 8.1% | 8.1% | 6.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Reserves | 75.11 | 84.12 | 91.16 | 101 | 118 | 135 | 170 | 205 | 253 | 291 | 333 | 383 |
| Borrowings | 5.02 | 2.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 |
| Other Liabilities | 9.04 | 8.04 | 10.05 | 12.06 | 11.06 | 10.05 | 17.08 | 14.07 | 20.10 | 18.09 | 21.10 | 17.08 |
| Total Liabilities | 92.18 | 97.18 | 106 | 117 | 132 | 149 | 190 | 223 | 276 | 312 | 358 | 405 |
| Fixed Assets | 11.04 | 21.07 | 52.17 | 51.15 | 50.14 | 46.16 | 89.28 | 91.28 | 96.33 | 99.35 | 101 | 48.16 |
| CWIP | 2.01 | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Investments | 13.98 | 31.97 | 22.96 | 19.98 | 36.96 | 17.98 | 29.94 | 3.99 | 8.99 | 42.94 | 56.94 | 209 |
| Other Assets | 65.15 | 43.13 | 29.09 | 45.14 | 44.12 | 84.29 | 70.16 | 126 | 169 | 169 | 199 | 147 |
| Inventories | 32.07 | 23.03 | 8.01 | 10.02 | 12.02 | 10.01 | 30.04 | 65.16 | 58.10 | 22.03 | 47.09 | 32.06 |
| Trade receivables | 5.99 | 5.99 | 4.99 | 8.98 | 8.98 | 7.99 | 8.98 | 9.98 | 12.97 | 13.96 | 15.96 | 9.97 |
| Cash & equivalents | 15.98 | 3.99 | 0.00 | 4.99 | 2.99 | 40.95 | 2.99 | 35.97 | 85.83 | 122 | 6.99 | 13.98 |
| Total Assets | 92.18 | 97.18 | 106 | 117 | 132 | 149 | 190 | 223 | 276 | 312 | 358 | 405 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.00 | 18.02 | 21.04 | 1.01 | 15.03 | 13.03 | 16.03 | 11.03 | 60.09 | 69.16 | −104 | 87.22 |
| Cash from investing activity | 12.97 | −25.95 | −23.97 | 4.99 | −15.98 | 25.96 | −53.88 | 25.93 | −7.98 | −29.95 | −6.99 | −76.86 |
| Cash from financing activity | −1.01 | −3.99 | −1.01 | −1.99 | −1.01 | −1.01 | −1.01 | −3.01 | −2.99 | −3.01 | −3.01 | −3.01 |
| Net cash flow | 11.96 | −11.95 | −3.99 | 4.98 | −1.99 | 37.84 | −38.82 | 33.89 | 48.80 | 35.87 | −115 | 6.97 |
| Capex | 9.04 | 11.04 | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.02 | 5.02 | 7.03 | 0.00 |
| Free cash flow | −9.98 | 6.98 | 18.98 | 0.99 | 13.98 | 12.97 | 14.98 | 10.98 | 56.85 | 64.93 | −111 | 106 |
| CFO / OP % | 38.1% | 186.0% | 226.0% | 37.0% | 111.0% | 100.1% | 61.0% | 54.0% | 123.0% | 197.0% | −194.0% | 242.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 24 | 29 | 27 | 31 | 26 | 25 | 21 | 20 | 20 | 25 | 32 | 17 |
| Inventory days | 251 | 220 | 69 | 58 | 52 | 55 | 175 | 308 | 194 | 79 | 209 | 101 |
| Days payable | 35 | 39 | 35 | 19 | 9 | 15 | 31 | 23 | 12 | 13 | 24 | 10 |
| Cash conversion cycle | 243 | 212 | 64 | 73 | 72 | 67 | 167 | 308 | 205 | 94 | 219 | 111 |
| Working capital days | 138 | 119 | 44 | 73 | 65 | 39 | 80 | 142 | 95 | 47 | 174 | 164 |
| ROCE % | 26.0% | 16.0% | 13.0% | 20.0% | 21.0% | 17.0% | 30.0% | 26.0% | 29.0% | 19.0% | 18.0% | 14.9% |
For the Jun 2026 quarter, Indo Borax & Chemicals reported sales of ₹69.93 Cr, up 29.6% year on year and net profit of ₹15.94 Cr, up 59.9% year on year. The operating margin was 28.1%.
Indo Borax & Chemicals' sales for the year to Mar 2026 were ₹215 Cr; over the last twelve months they were ₹232 Cr.
Net profit for the year to Mar 2026 was ₹49.86 Cr, and ₹55.81 Cr over the last twelve months. Earnings per share over the same trailing period were ₹17.57.
Indo Borax & Chemicals reported borrowings of ₹1.01 Cr at Mar 2026, against cash and equivalents of ₹13.98 Cr.
Cash from operations was ₹87.22 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹106 Cr.